<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41">
 <label>41.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sanchis-Gomar</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Lavie</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Perez-Quilis</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Henry</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Lippi</surname>
    <given-names>G</given-names>
   </name>
  </person-group>. 
  <article-title>Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019</article-title>. 
  <source>Mayo Clinic Proceedings.</source> (
  <year>2020</year>) 
  <volume>95</volume>:
  <fpage>1222</fpage>â€“
  <lpage>30</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.mayocp.2020.03.026</pub-id>
  <?supplied-pmid 32376099?>
  <pub-id pub-id-type="pmid">32376099</pub-id>
 </mixed-citation>
</ref>
